[1]
|
Engel JJr. Overview of functional neuroimaging in epilepsy[J]. Adv Neurol, 2000, 83:1-9. |
[2]
|
Constantinidis I. MRS methodology[J]. Adv Neurol, 2000, 83:235-246. |
[3]
|
Maton BM, Kuzniecky RI. Proton MRS:N-acetylaspatate, cteatine,and choline[J]. Adv Neuro, 2000, 83:253-259. |
[4]
|
Spencer SS, Bautista RE. Functional neuroimaging in localization of the ictal onset zone[J]. Adv Neurol, 2000, 83:285-296. |
[5]
|
Cendes F, Caramanos Z, Andermann F, et al. Proton magnetic resonance spectroscopic imaging and magnetic resonance imaging volumetry in the lateralization of temporal lobe epilepsy:a series of 100patients[J]. Ann Neurol, 1997, 42(5):737-746. |
[6]
|
Cendes F, Andermann F, Dubeau F, et al. Normalization of neuronal metabolic dysfunction after surgery for temporal lobe epilepsy. Evidence from proton MR spectroscopic imaging[J]. Neurology, 1997,49(6):1525-1533. |
[7]
|
Laxer KD. Phosphorus MRS:pH, ATP, PCr[J]. Adv Neurol, 2000,83:273-277. |
[8]
|
Theodore WH. PET:cerebral blood flow and glucose metabolismpathophysiology and drug effects[J]. Adv Neuro, 2000, 83:121-130. |
[9]
|
O'Brien TJ, Newton MR, Cook MJ, et al. Hippocampal atrophy is not a major determinant of regional hypometabolism in temporal lobe epilepsy[J]. Epilepsia, 1997, 38:74-80. |
[10]
|
Theodore WH, Gaillard WD. Positron emission tomography in neocortical epilepsies[J]. Adv Neuro, 2000, 84:435-446. |
[11]
|
Alexander H, Matthias J, Koepp, et al. Grey and white matter flumazenil biding in neocortical epilepsy with normal MRI. A PET study of 44 patients[J]. Brain, 2003, 126(pt6):1300-1318. |
[12]
|
Anny S, Paul D, Violina L, et al. Increased expression of "peripheral-type" benzodiazepine receptors in human temporal lobe epilepsy:implications for PET imaging of hippocampal sclerosis[J]. Metab Brain Dis, 2002, 17(1):3-11. |
[13]
|
Hammers A, Koepp MJ, Richardsons MP, et al. Central benzodiazepine receptors in malformations of cortical development:a quantitative study[J]. Brain, 2001, 124(pt8):1555-1565. |
[14]
|
Richardson MP, Keopp MJ, Brooks DJ, et al. 11C-flumazenil PET in neocortical epilepsy[J]. Neurology, 1998, 51(2):485-492. |
[15]
|
Muzik O, da Silva EA, Juhasz C, et al. Intracranial EEG versus flumazenil and glucose PET in children with extrateporal lobe epilepsy[J]. Neurology, 2000, 54(1):171-179. |
[16]
|
Lewis PJ, Siegel A, Siegel AM, et al. Does performing image registration and subtraction in ictal brain SPECT help localize neocortical seizures?[J]. J Nucl Med, 2000, 41(10):1619-1626. |
[17]
|
Stefan H, Hopp P, Platsch G, et al. SPECT:ictal perfusion in localization-related epilepsies[J]. Adv Neurol, 2000, 83:41-50. |
[18]
|
Lancman ME, Morris HH Ⅲ, Raja S, et al. Usefulness of ictal and interical 99mTc ethyl cysteinate dimer single photon emission computed tomography in patients with refractory partial epilepsy[J]. Epilepsia,1997, 38(4):466-471. |
[19]
|
O'Brien TJ, So EL, Mullan BP, et al. Subtraction ictal SPECT coregistered to MRI improves clinical usefulness of SPECT in localizing the surgical seizure focus[J]. Neurology, 1998, 50(2):445-454. |
[20]
|
Cascino GD. Advances in neuroimaging:surgical localization[J].Epilepsia, 2001, 42(1):3-12. |
[21]
|
So EL. Integration of EEG, MRI, and SPECT in localizing the seizure focus for epilepsy surgery[J]. Epilepsia, 2000, 41(Suppl 3):S48-S54. |
[22]
|
Viviane B, Paola V, Edouard H, et al. Correlation between PET and SISCOM in temporal lobe epilepsy[J]. J Nucl Med, 2002, 43(8):991-998. |